PharmaBoardroom

Interview: Paulo Wickbold Marques – Head of Operations,…

Upon opening an R&D center in Mississauga in 2017, Biolab Pharma Canada, headed by Paulo Wickbold Marques, became the first Brazilian…

Interview: Evija Buksa – Managing Director Latvia/ General…

Evija Buksa, general manager at Merck in Latvia, explains the strong history of Merck in the country as well as its key role in participating in the…

Interview: Maryse Laliberté – Vice President & General…

Halo Pharma, a US-based one-stop-shop CDMO (Contract Development and Manufacturing Organization), operates out of a site in Mirabel, close to…

Interview: Juan Carlos Galarza – Executive Director, ARCSA

Juan Carlos Galarza, executive director of Ecuador’s National Health Regulation, Control and Surveillance Agency (ARCSA), discusses the multiple…

The UK Life Sciences Ecosystem: A Snapshot

Much of the new inward investment in the UK from international pharmaceutical companies is from those that wish their discovery science to be in…

Interview: Daniel Dereser – CEO, Boiron Canada

Boiron Canada is the sixth largest affiliate of Boiron’s global operations (in terms of sales), and under Daniel Dereser’s leadership, the company…

Simon Gillespie – Chief Executive, British Heart Foundation…

Simon Gillespie of the British Heart Foundation (BHF), the UK’s leading national heart charity, outlines the organization’s mission, the issues…

Hilary Evans – Chief Executive, Alzheimer’s Research UK

Hilary Evans of Alzheimer’s Research UK (ARUK), the UK’s leading national research charity in the field of dementia, discusses her…

Interview: Vatché Bartekian – President, Vantage…

Introducing Vantage BioTrials, a CRO focused on operational excellence with a lean and holistic approach to each project, Vatché Bartekian, president…

Canada Medtech Facts & Figures Snapshot

Canadian medtech at a glance: market value, number of companies, number of employees,export markets, spinoffs. Key areas of…

Interview: Allan O’Dette – Chief Investment Officer,…

Allan O’Dette has been at the helm of the Ontario Investment Office since April 2017. As CIO, he underlines the importance of the life sciences…

Interview: Dorota Hryniewiecka-Firlej – President, Pfizer…

Dorota Hryniewiecka-Firlej, president of Pfizer Poland, discusses the current state of the Polish innovation landscape and importance of a tight-knit…

Tagged with